Tesla, Inc. vs AbbVie Inc.
Tesla, Inc. is worth $1.366T, 2.9× the $464.575B market cap of AbbVie Inc.. Updated daily.
| Metric | Tesla, Inc.TSLA ![]() | AbbVie Inc.ABBV ![]() |
|---|---|---|
| Market cap | $1.366T | $464.575B |
| Global rank | #1 | #2 |
| Share price | $345.82 | $262.90 |
| Change | +3.91% | +5.12% |
| Revenue | $94.827B | $61.160B |
| Net income | $3.794B | $4.226B |
| Country | United States | United States |
| Sector | Consumer Cyclical | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Tesla, Inc. bigger than AbbVie Inc.?
- Tesla, Inc. has a market cap of $1.366T against $464.575B for AbbVie Inc., making it 2.9 times as valuable.
- Which company earns more, TSLA or ABBV?
- Tesla, Inc. reported net income of $3.794B and AbbVie Inc. reported $4.226B in their most recent annual periods.

